当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Hepatology ( IF 12.9 ) Pub Date : 2022-01-06 , DOI: 10.1002/hep.32313
Marina Serper 1, 2, 3 , Neehar D Parikh 4 , Grace Thiele 1 , Nadia Ovchinsky 5 , Shivang Mehta 6 , Alexander Kuo 7 , Chanda Ho 8 , Fasiha Kanwal 9, 10, 11 , Michael Volk 12 , Sumeet K Asrani 13 , Marwan S Ghabril 14 , John R Lake 15 , Raphael B Merriman 16 , Timothy R Morgan 17 , Elliot B Tapper 4, 18
Affiliation  

HCC is a leading cause of mortality in patients with advanced liver disease and is associated with significant morbidity. Despite multiple available curative and palliative treatments, there is a lack of systematic evaluation of patient-reported outcomes (PROs) in HCC.

中文翻译:

HCC 患者报告的结果:美国肝病研究协会实践指标委员会的范围界定审查

HCC 是晚期肝病患者死亡的主要原因,并且与显着的发病率相关。尽管有多种可用的治愈性和姑息性治疗,但仍缺乏对 HCC 患者报告结果 (PRO) 的系统评估。
更新日期:2022-01-06
down
wechat
bug